PolyPid (PYPD)
(Delayed Data from NSDQ)
$3.53 USD
-0.12 (-3.29%)
Updated Aug 2, 2024 03:58 PM ET
After-Market: $3.55 +0.02 (0.57%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
PolyPid Ltd. [PYPD]
Reports for Purchase
Showing records 1 - 7 ( 7 total )
Company: PolyPid Ltd.
Industry: Medical - Drugs
KOL Event Showcases Surgical Site Infection Program; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: PolyPid Ltd.
Industry: Medical - Drugs
SHIELD II Trial Progress; 1Q24 Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: PolyPid Ltd.
Industry: Medical - Drugs
Key Enrollment Milestone Reached in SHIELD II Pivotal Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: PolyPid Ltd.
Industry: Medical - Drugs
SHIELD II Enrollment Milestone; 2023 Financials; Lowering PT to $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: PACHAIYAPPAN B
Company: PolyPid Ltd.
Industry: Medical - Drugs
SHIELD II Phase 3 Trial Advancing; 3Q23 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PACHAIYAPPAN B
Company: PolyPid Ltd.
Industry: Medical - Drugs
Solving Surgical Site Infections; Initiating at Buy and $16 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PACHAIYAPPAN B
Company: PolyPid Ltd.
Industry: Medical - Drugs
|